Skip to content
Fullscript leaf logo Sign in
Fullscript logo
Fullscript leaf logo
  • Our platform
    • Practitioner software
    • Pricing
    • Integrations
    • Patients on Fullscript
    • Book a demo
  • Learn
    • Spotlight
    • Protocols
    • Wellness blog
    • Practice resources
    • Webinars
    • Ingredient library
    • Practicing virtually
  • Support
    • Practitioner support
    • Patient help
    • Chat with us
Sign in Create account
News
—

CDC Reported Jump in Melatonin Poisoning

June 22, 2022
Fact checked
Written by Dr. Eric Viegas, ND
  1. Wellness blog
  2. CDC Reported Jump in Melatonin Poisoning

Melatonin is a dietary supplement regulated by the U.S. Food and Drug Administration (FDA) and available over the counter in a variety of delivery formats in the United States. Melatonin supplements may help regulate circadian rhythm to address insomnia in adults and primary sleep disorders in children. (2)(5)(6) Adults may opt for melatonin supplements over certain pharmaceuticals used for sleep issues that may lead to dependency. However, it’s important for all consumers to understand the realities of melatonin side effects. Recently, a report released by the Centers for Disease Control and Prevention (CDC) detailed a dramatic 530% rise over the last ten years in pediatric ingestions of melatonin, poisoning reports, and severe adverse events. (4) So how much melatonin is too much melatonin? Keep reading to learn more about how this commonly used sleep aid is being unintentionally ingested by children leading to overdose and posioning. 

melatonin poisoning
The CDC has reported a 530% rise over the last ten years in pediatric ingestions of melatonin.

What you need to know about the rise in melatonin poisoning 

In the past two years, melatonin use has dramatically increased, leading to an increased risk of children ingesting these products unintentionally. As a result, melatonin-related poison control center reports accounted for 4.9% of all pediatric ingestions reported in 2021. (4) The majority of these melatonin ingestions were unintentional, involved male children under five years of age, and occurred at home. Thankfully, most children were asymptomatic, but a small percentage of children were hospitalized and required intensive care. (4)

A number of factors may be contributing to an increase in melatonin poisoning in children and toddlers, including:

  • There has been a rise in consumer demand due to an increase in insomnia concerns during the pandemic, sparking substantial 150% growth of the national melatonin market from 2016 to 2020. (4)
  • Melatonin products are available in chewable and gummy formats—both of which are very appealing to a child.
  • The largest increase in pediatric ingestion was seen at the onset of the pandemic, during daycare and school closures.
  • Products may not be stored safely at home, resulting in easy access for children when unattended.
  • Generally, low-quality over-the-counter melatonin products have a high variability in dose compared to label claims (-83% to +478%), lot-to-lot variability that may sometimes approach 465%, and contamination concerns with adulterants like serotonin (5-HTP). Chewables typically have the highest variability in dose compared to other delivery formats. (1)(3)

The bottom line

Reported melatonin poisonings are on the rise, especially among young children. Keep your children safe by storing all supplements in a secure, safe place. If your child experiences a melatonin overdose, contact poison control at 1-800-222-1222 in the U.S. or 1-800-268-9017 in Canada, or call 911 in the event of a medical emergency. 

Fullscript’s commitment to quality ensures safe and effective treatment outcomes. To learn more about Fullscript’s commitment quality, visit the Fullscript blog.

Fullscript simplifies supplement dispensing

Create your dispensary today I'm a patient
References
  1. Erland, L. A., & Saxena, P. K. (2017). Melatonin natural health products and supplements: Presence of serotonin and significant variability of melatonin content. Journal of Clinical Sleep Medicine, 13(02), 275–281. 
  2. Garfinkel, D., Laudon, M., Nof, D., & Zisapel, N. (1995). Improvement of sleep quality in elderly people by controlled-release melatonin. The Lancet, 346(8974), 541–544. 
  3. Grigg-Damberger, M. M., & Ianakieva, D. (2017). Poor quality control of Over-the-Counter melatonin: What they say is often not what you get. Journal of Clinical Sleep Medicine, 13(02), 163–165. 
  4. Lelak, K., Vohra, V., Neuman, M. I., Toce, M. S., & Sethuraman, U. (2022, June 2). Pediatric melatonin ingestions. Centers for Disease Control and Prevention. https://www.cdc.gov/mmwr/volumes/71/wr/mm7122a1.htm?s_cid=mm7122a1_w 
  5. Lemoine, P., Nir, T., Laudon, M., & Zisapel, N. (2007). Prolonged-release melatonin improves sleep quality and morning alertness in insomnia patients aged 55 years and older and has no withdrawal effects. Journal of Sleep Research, 16(4), 372–380.
  6. Wade, A. G., Ford, I., Crawford, G., McConnachie, A., Nir, T., Laudon, M., & Zisapel, N. (2010). Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: A randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety. BMC Medicine, 8(1), 51.
  • Print
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • Pinterest

Disclaimer

The information in this article is designed for educational purposes only and is not intended to be a substitute for informed medical advice or care. This information should not be used to diagnose or treat any health problems or illnesses without consulting a doctor. Consult with a health care practitioner before relying on any information in this article or on this website.

Cancel reply

Your email address will not be published. Required fields are marked *

Prev Next
Back to main wellness blog page

Get more resources for your practice

Protocols
Practice resources
Ingredient library
Webinars

Share

  • Print
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • Pinterest

Fullscript content philosophy

At Fullscript, we are committed to curating accurate, and reliable educational content for practitioners and patients alike. Our educational offerings cover a broad range of topics related to integrative medicine, such as supplement ingredients, diet, lifestyle, and health conditions.

Medically reviewed by expert practitioners and our internal Integrative Medical Advisory team, all Fullscript content adheres to the following guidelines:

  1. In order to provide unbiased and transparent education, information is based on a research review and obtained from trustworthy sources, such as peer-reviewed articles and government websites. All medical statements are linked to the original reference and all sources of information are disclosed within the article.
  2. Information about supplements is always based on ingredients. No specific products are mentioned or promoted within educational content.
  3. A strict policy against plagiarism is maintained; all our content is unique, curated by our team of writers and editors at Fullscript. Attribution to individual writers and editors is clearly stated in each article.
  4. Resources for patients are intended to be educational and do not replace the relationship between health practitioners and patients. In all content, we clearly recommend that readers refer back to their healthcare practitioners for all health-related questions.
  5. All content is updated on a regular basis to account for new research and industry trends, and the last update date is listed at the top of every article.
  6. Potential conflicts of interest are clearly disclosed.
Read more
Fullscript logo

We're certified carbon-neutral. It's part of our commitment to helping people get better.

Canadian flag - toggles to show canada specific contentCanada
American flag - toggles to show american specific contentUnited States
Product
  • Practitioner software
  • Integrations
  • Pricing
  • Patients
  • Supplement quality
  • Treatment adherence
  • Catalog
  • Wholesale
Company
  • Spotlight
  • About Fullscript
  • Collective
  • Leadership
  • Culture guide
  • Careers
  • Engineering
  • News
Support
  • Practitioner support
  • Patient help
  • Testimonials
  • General FAQ
  • Patient shipping
  • Wholesale shipping

© Fullscript 2022. All rights reserved.

  • Privacy Statement
  • Terms of Service
  • Accessibility Policy
  • Customer Support Policy
  • Acceptable Use Policy
  • California Privacy Notice
Send this to a friend